OptraSCAN Advances Global Expansion with U.S. FDA Clearance
OptraSCAN, a California-headquartered digital pathology and image analysis company backed by Molbio Diagnostics, has received U.S. Food and Drug Administration […]
BREAST-CANCER-DIAGNOSTICS
OptraSCAN, a California-headquartered digital pathology and image analysis company backed by Molbio Diagnostics, has received U.S. Food and Drug Administration […]
